Arnatar Therapeutics

Arnatar Therapeutics is a biotech company in San Diego, United States, founded in 2022. It has raised $52.0M across 2 rounds, most recently a $52.0M Series A in April 2024.

Arnatar

Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$52.0M
Last Round
$52.0M Series AApr 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

We are a San Diego-based RNA company pioneering novel therapeutics that aim to address high unmet medical needs in cardiovascular, metabolic, rare liver, kidney, and CNS diseases. Our proprietary DARGER™ platform enables both gene upregulation and downregulation using novel antisense oligonucleotide (ASO) and small interfering RNA (siRNA) approaches.

Summary

It lists 11–50 employees. It has raised $52.0M in total across 2 rounds, most recently a $52.0M Series A round in Apr 2024. Investors include Eight Roads Ventures, 3E Bioventures Capital and Apricot Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AApr 2024
$52.0M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Arnatar Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/arnatar-therapeutics"><img src="https://indexed.vc/api/badge/company/arnatar-therapeutics" alt="Arnatar Therapeutics on Indexed.vc" width="260" height="76" /></a>